The diagnostic value of tau protein, β-amyloid (1-42) and their ratio for the discrimination of alcohol-related cognitive disorders from Alzheimer's disease in the early stages

International Journal of Geriatric Psychiatry

Volumn 20, Issue 8, 2005, Pages 722-729

  Kapaki, Elisabeth ^a   Liappas, Ioannis ^a   Paraskevas, George P ^a   Theotoka, Ilia ^a   Rabavilas, Andreas ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

amyloid (1 42); Alcohol related cognitive disorders; Alzheimer's disease; Cerebrospinal fluid; Chronic alcohol dependence; Tau protein

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; TAU PROTEIN;

ADULT; AGED; AGING; ALCOHOL CONSUMPTION; ALCOHOLISM; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; COGNITIVE DEFECT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; ELDERLY CARE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

AGING; ALCOHOLISM; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BIOLOGICAL MARKERS; CHRONIC DISEASE; COGNITION DISORDERS; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; STATISTICS; TAU PROTEINS;

EID: 23844540380     PISSN: 08856230     EISSN: None     Source Type: Journal    
DOI: 10.1002/gps.1351     Document Type: Article

References (43)

1. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association: Washington, DC.
2. Andreasen N, Minthon L, Clarberg A, et al. 1999. Sensitivity, specificity and stability of CSF-tau in a community-based patient sample. Neurology 53: 1488-1494.
3. Arendt T. 1993. The cholinergic deafferentation of the cerebral cortex induced by chronic consumption of alcohol: reversal by cholinergic drugs and transplantation. In Alcohol-Induced Brain Damage, Hunt WA, Nixon SJ (eds). Department of Health and Human Services: Rockville, MD; 431-460.
4. Blennow K, Hampel H. 2003. CSF markers for incipient Alzheimer's disease. Lancet Neurol 2: 605-613.
5. Blennow K, Wallin A, Agren H, Spenger C, Siegfried J, Vanmechelen E. 1995. Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer's disease? Mol Chem Neuropathol 26: 231-245.
6. Blow F, Cook FL, Booth B, et al. 1992. Age-related psychiatric comorbidities and level of function in alcohol veterans seeking outpatient treatment. Hosp Community Psychiatry 43: 990-995.
7. Brun A, Andersson J. 2001. Frontal dysfunction and frontal cortical synapse loss in alcoholism-the main cause of alcoholic dementia? Dement Geriatr Cogn Disord 12: 289-294.
8. Carlen PL, Wilkinson DA. 1987. Reversibility of alcohol-related brain damage: clinical and experimental observations. Acta Med Scand 717(Suppl.): 19-26.
9. Clark CM, Xie S, Chittams J, et al. 2003. Cerebrospinal fluid tau and beta-amyloid - how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch Neurol 60: 1696-1702.
10. Cullen KM, Halliday GM. 1995. Neurofibrillary tangles in chronic alcoholics. Neuropath Appl Neurobiol 21: 312-318.
11. Friedland RP. 1993. Alzheimer's disease: clinical features and differential diagnosis. Neurology 43(Suppl. 4): S45-S51.
12. Folstein M, Folstein S, McHugh PR. 1975. 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198.
13. Galasko D, Hansen LA, Katzman R, et al. 1994. Clinical-neuropathological correlations in Alzheimer's disease and related dementias. Arch Neurol 51: 888-895.
14. Gilleard CJ, Kellett JM, Coles JA, Millard PH, Honavar M, Lantos PL. 1992. The St George's dementia bed investigation study. Acta Psychiatr Scand 85: 264-269.
15. Harper C, Butterworth R. 1997. Nutritional and metabolic disorders. In Greenfield's Neuropathology, 6th edn, Graham DI, Lantos PL (eds). Arnold: London; 600-655.
16. Hughes PH, Venulet J, Khant U, et al. 1980. Core data for epidemiological studies on nonmedical drug use. WHO Offset publ 56: 1-100.
17. Jellinger K, Danielczyk W, Fischer P, Gabriel E. 1990. Clinicopathological analysis of dementia disorders in the elderly. J Neurol Sci 95: 239-258.
18. Jernigan TL, Butters N, DiTraglia G, et al. 1991. Reduced cerebral grey matter observed in alcoholics using magnetic resonance imaging. Alcohol Clin Exp Res 15: 418-427.
19. Kanemaru K, Kameda N, Yamanouchi H. 2000. Decreased CSF amyloid β42 and normal tau levels in dementia with Lewy bodies. Neurology 54: 1875-1876.
20. Kapaki E, Paraskevas GP, Zalonis I, Zournas C. 2003. CSF tau protein and β-amyloid (1-42) in Alzheimer's disease diagnosis: discrimination from normal ageing and other dementias in the Greek population. Eur J Neurol 10: 119-128.
21. Klatka LA, Schiffer RB, Powers JM, Kazee AM. 1996. Incorrect diagnosis of Alzheimer's disease: a clinicopathologic study. Arch Neurol 53: 35-42.
22. Knopman D. 2001. Cerebrospinal fluid β-amyloid and tau proteins for the diagnosis of Alzheimer's disease. Arch Neurol 58: 349-350.
23. Korbo L. 1999. Glial cell loss in the hippocampus of alcoholics. Alc Clin Exp Res 23: 164-168.
24. Kril JJ, Halliday GM. 1999. Brain shrinkage in alcoholics: a decade on and what have we learned? Prog Neurobiol 58: 381-387.
25. Lopez OL, Becker JT, Klunk W, et al. 2000. Research evaluation and diagnosis of probable Alzheimer's disease over the last two decades: I. Neurology 55: 1854-1862.
26. McKhann G, Drachman D, Folstein M, et al. 1984. Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34: 939-944.
27. Mendez M, Mastri AR, Sung JH, Frey WH 2nd. 1992. Clinically diagnosed Alzheimer's disease: neuropathologic findings in 650 cases. Alzheimer Dis Assoc Disord 6: 35-43.
28. Mori H, Hosoda K, Matsubara E, et al. 1995. Tau in cerebrospinal fluids: establishment of the sandwich ELISA with antibody specific to the repeat sequence in tau. Neurosci Lett 186: 181-183.
29. Morikawa Y, Arai H, Matsushita S, et al. 1999. Cerebrospianl fluid tau protein levels in demented and nondemented alcoholics. Alcohol Clin Exp Res 23: 575-577.
30. Oslin D, Atkinson RM, Smith DM, Hendrie H. 1998. Alcohol related dementia: proposed Clinical Criteria. Int J Geriatr Psychiatry 13: 203-212.
31. Risse SC, Raskind MA, Nochlin D, et al. 1990. Neuropathological findings in patients with clinical diagnoses of probable Alzheimer's disease. Am J Psychiatry 147: 168-171.
32. The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute of Aging Working Group. 1998. Concensus Report of the Working Group on: 'Molecular and Biochemical Markers of Alzheimer's disease'. Neurobiol Aging 19: 109-116.
33. Saunders PA, Copeland JR, Dewey ME, et al. 1991. Heavy drinking as a risk factor for depression and dementia in elderly men. Findings from the Liverpool longitudinal community study. Br J Psychiatry 159: 213-216.
34. Saxton J, Munro CA, Butters MA, Schramke C, McNeil MA. 2000. Alcohol, dementia, and Alzheimer's disease: comparison of neuropsychological profiles. J Geriatr Psychiatry Neurol 13: 141-149.
35. Smith DM, Atkinson RM. 1995. Alcoholism and dementia. Int J Addictions 30: 1843-1869.
36. Sobów T, Flirski M, Liberski PP. 2004. Amyloid-beta and tau proteins as biochemical markers of Alzheimer's disease. Acta Neurobiol Exp 64: 53-70.
37. Takeda M, Tanaka T, Nakamura Y, Kudo T, Kamino K. 2001. Amyloid_42 & tau levels in CSF-diagnostic markers for Alzheimer's disease. Int Psychogeriatr 13(Suppl. 2): 214-S.
38. Tombaugh TN, McIntyre NJ. 1992. The mini-mental stage examination: a comprehensive review. J Am Geriatr Soc 40: 992.
39. Tsolaki M, Foundoulakis C, Pavlopoulos I, et al. 1999. Prevalence and incidence of Alzheimer's disease and other dementing disorders in Pylea, Greece. Am J Alz Dis 14: 138-148.
40. Victor M. 1994. Alcoholic dementia. Can J Neurol Sci 21: 88-99.
41. Wallin A, Blennow K. 1996. Clinical subgroups of the Alzheimer's syndrome. Acta Neurol Scand 165(Suppl.): S51-S57.
42. Wells JC, Tien AY, Garrison R, Eaton WW. 1994. Risk factors for the incidence of social phobia as determined by the Diagnostic Interview Schedule in a population-based study. Acta Psychiatr Scand 90: 84-90.
43. World Health Organization. Composite International Diagnostic Interview-CIDI, Core Version 1.0. 1990. WHO: Geneva, Division of Mental Health.